Functional dissection of Alzheimer’s disease brain gene expression signatures in humans and mouse models

Human brain transcriptomes can highlight biological pathways associated with Alzheimer’s disease (AD); however, challenges remain to link expression changes with causal triggers. We have examined 30 AD-associated, gene coexpression modules from human brains for overlap with 251 differentially-expressed gene sets from mouse brain RNA-sequencing experiments, including from models of AD and other neurodegenerative disorders. Human-mouse overlaps highlight responses to amyloid versus neurofibrillary tangle pathology and further reveal age- and sex-dependent expression signatures for AD progression. Human coexpression modules enriched for neuronal and/or microglial genes overlap broadly with signatures from mouse models of AD, Huntington’s disease, Amyotrophic Lateral Sclerosis, and also aging. Several human AD coexpression modules, including those implicated in the unfolded protein response and oxidative phosphorylation, were not activated in AD models, but instead were detected following other, unexpected mouse genetic manipulations. Our results comprise a powerful, cross-species resource and pinpoint experimental models for diverse features of AD pathophysiology from human brain transcriptomes.

[1]  Hui Zheng,et al.  Practical considerations for choosing a mouse model of Alzheimer’s disease , 2017, Molecular Neurodegeneration.

[2]  J. Klappenbach,et al.  Human Alzheimer’s disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology , 2018, Journal of Neuroinflammation.

[3]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[4]  Jeffrey H. Chuang,et al.  Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation , 2016, eLife.

[5]  James A. Eddy,et al.  Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases , 2016, Scientific Data.

[6]  Cory C. Funk,et al.  Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases , 2018, Alzheimer's & Dementia.

[7]  T. Wisniewski,et al.  Alzheimer’s disease: experimental models and reality , 2017, Acta Neuropathologica.

[8]  M. Block,et al.  Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism , 2005, Progress in Neurobiology.

[9]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[10]  James A. Eddy,et al.  Meta-analysis of the human brain transcriptome identifies heterogeneity across human AD coexpression modules robust to sample collection and methodological approach , 2019, bioRxiv.

[11]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[12]  C. Ross,et al.  Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.

[13]  F. Edwards,et al.  A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. , 2015, Cell reports.

[14]  Manolis Kellis,et al.  Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease , 2015, Nature.

[15]  J. Götz,et al.  Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.

[16]  Li-Huei Tsai,et al.  Aberrant Cdk5 Activation by p25 Triggers Pathological Events Leading to Neurodegeneration and Neurofibrillary Tangles , 2003, Neuron.

[17]  A. Nógrádi,et al.  Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. , 2009, Brain : a journal of neurology.

[18]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[19]  Bin Zhang,et al.  Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease , 2017, Molecular Neurodegeneration.

[20]  Salvador Ventura,et al.  Protein misfolding diseases , 2015, Future science OA.

[21]  Reductions in hypothalamic Gfap expression, glial cells and α-tanycytes in lean and hypermetabolic Gnasxl-deficient mice , 2016, Molecular Brain.

[22]  A. Plagge,et al.  Elevated blood pressure, heart rate and body temperature in mice lacking the XLαs protein of the Gnas locus is due to increased sympathetic tone , 2013, Experimental physiology.

[23]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[24]  Andre Altmann,et al.  Sex modifies the APOE‐related risk of developing Alzheimer disease , 2014, Annals of neurology.

[25]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[26]  H. Kornblum,et al.  Interactive Regulation of Neuronal Development by Hippocampal Stem Cell Niche Populations , 2019, Neuron.

[27]  Madhav Thambisetty,et al.  A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease. , 2017, Cell systems.

[28]  Xia Yang,et al.  Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases , 2014 .

[29]  T. Iwaki,et al.  Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation , 2017, Scientific Reports.

[30]  Nick C Fox,et al.  Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.

[31]  K. Blennow,et al.  Alzheimer's disease , 2016, The Lancet.

[32]  D. Lomas,et al.  Endoplasmic reticulum dysfunction in neurological disease , 2013, The Lancet Neurology.

[33]  P. Hof,et al.  The isotropic fractionator provides evidence for differential loss of hippocampal neurons in two mouse models of Alzheimer's disease , 2012, Molecular Neurodegeneration.

[34]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[35]  J. Güell-Bosch,et al.  Mouse Models of Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[36]  B. Winblad,et al.  APP mouse models for Alzheimer's disease preclinical studies , 2017, The EMBO journal.

[37]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[38]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[39]  G. Howell,et al.  Toward more predictive genetic mouse models of Alzheimer's disease , 2016, Brain Research Bulletin.

[40]  K. Ashe,et al.  Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L) , 2005, The Journal of Neuroscience.

[41]  R. Leite,et al.  Transcriptomic analysis of purified human cortical microglia reveals age-associated changes , 2017, Nature Neuroscience.

[42]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[43]  G. Smyth,et al.  ROBUST HYPERPARAMETER ESTIMATION PROTECTS AGAINST HYPERVARIABLE GENES AND IMPROVES POWER TO DETECT DIFFERENTIAL EXPRESSION. , 2016, The annals of applied statistics.

[44]  Tim Clark,et al.  Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer’s disease , 2018, Proceedings of the National Academy of Sciences.

[45]  Andrew H. Chiang,et al.  Protein Misfolding Diseases. , 2017, Annual review of biochemistry.

[46]  A. Goate,et al.  Alzheimer’s Disease Genetics: From the Bench to the Clinic , 2014, Neuron.

[47]  A. Blockeel,et al.  Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy , 2017, Alzheimer's Research & Therapy.

[48]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[49]  David A Bennett,et al.  Religious Orders Study and Rush Memory and Aging Project. , 2018, Journal of Alzheimer's disease : JAD.

[50]  Alexander A. Morgan,et al.  Mouse models rarely mimic the transcriptome of human neurodegenerative diseases: A systematic bioinformatics-based critique of preclinical models. , 2015, European journal of pharmacology.

[51]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[52]  C. Reitz Novel susceptibility loci for Alzheimer's disease. , 2015, Future neurology.

[53]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[54]  Benjamin A. Logsdon,et al.  The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease , 2018, Scientific Data.

[55]  S. Amor,et al.  Inflammation in CNS neurodegenerative diseases , 2018, Immunology.

[56]  M. Huentelman,et al.  Harnessing Genetic Complexity to Enhance Translatability of Alzheimer’s Disease Mouse Models: A Path toward Precision Medicine , 2019, Neuron.

[57]  Sean R. Davis,et al.  GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor , 2007, Bioinform..

[58]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[59]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[60]  F. Edwards,et al.  First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression , 2015, Brain : a journal of neurology.

[61]  C. Moriconi,et al.  Neuroserpin polymers cause oxidative stress in a neuronal model of the dementia FENIB , 2017, Neurobiology of Disease.

[62]  Sven Rahmann,et al.  Snakemake--a scalable bioinformatics workflow engine. , 2012, Bioinformatics.

[63]  Huihao Zhou,et al.  Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration , 2014, Science.

[64]  Rena Li,et al.  Sex differences in cognitive impairment and Alzheimer’s disease , 2014, Frontiers in Neuroendocrinology.

[65]  X. Yao,et al.  Sex Dimorphism Profile of Alzheimer’s Disease-Type Pathologies in an APP/PS1 Mouse Model , 2015, Neurotoxicity Research.

[66]  R. Mayeux,et al.  Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[67]  Frank M LaFerla,et al.  Animal models of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[68]  Charles C. White,et al.  A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease , 2018, Nature Neuroscience.

[69]  V. Lee,et al.  Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases , 2014, Nature Medicine.

[70]  Nicholas E. Propson,et al.  Concurrent cell type-specific isolation and profiling of mouse brains in inflammation and Alzheimer's disease. , 2018, JCI insight.

[71]  R. Nixon Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases , 2005, Neurobiology of Aging.

[72]  Galina A. Erikson,et al.  The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain , 2018, Cell reports.

[73]  E. Blalock,et al.  Transcriptional signatures of brain aging and Alzheimer’s disease: What are our rodent models telling us? , 2017, Behavioural Brain Research.

[74]  C. DeCarli,et al.  Impact of multiple pathologies on the threshold for clinically overt dementia , 2017, Acta Neuropathologica.

[75]  Anne-Laure Boulesteix,et al.  Regularized estimation of large-scale gene association networks using graphical Gaussian models , 2009, BMC Bioinformatics.

[76]  S. Lovestone,et al.  NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology , 2017, Redox biology.